[Clinical study on the anti-lipidemia and anti-steatosis effectiveness of the pantetheine-phosphorylcholine pharmacologic combination].
D000328:Adult; D000368:Aged; D002794:Choline / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005218:Fat Necrosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000188:drug therapy*; D010204:Pantetheine / Q000627:therapeutic use*; D010767:Phosphorylcholine / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D013438:Sulfhydryl Compounds; D010767:Phosphorylcholine; D010204:Pantetheine; D002794:Choline
Studio clinico dell'efficacia antidislipidemica ed antisteatosica dell'associazione farmacologica pantetina-fosforilcolina.